A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
ctDNA in HER2+ EBC Neoadjuvant Treatment
- Status
- RECRUITING
- Phase
- PHASE2
Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
- Status
- RECRUITING
- Phase
- PHASE3
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
PDT For Induction Therapy For Head And Neck Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
HB1801 Combined Treatment of HER2-positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2